Literature DB >> 17279219

Opioids for managing chronic non-malignant pain: safe and effective prescribing.

Meldon Kahan1, Anita Srivastava, Lynn Wilson, Angela Mailis-Gagnon, Deana Midmer.   

Abstract

OBJECTIVE: To review the evidence on safe and effective prescribing of opioids for chronic non-malignant pain. QUALITY OF EVIDENCE: MEDLINE was searched using the terms "opioid effectiveness" and "adverse effects." There is strong evidence that opioids are effective for both nociceptive and neuropathic pain, but limited evidence that they are effective for pain disorder. There is little information on their effectiveness at high doses or on the adverse effects of high doses. MAIN MESSAGE: Opioids should be initiated after an adequate trial of acetaminophen or nonsteroidal anti-inflammatory drugs for nociceptive pain and of tricyclic antidepressants or anticonvulsants for neuropathic pain. Patients should be asked to sign treatment agreements and to give informed consent to treatment. Patients should experience a graded analgesic response with each dose increase. Titrate doses of immediate-release opioids slowly upward until pain reduction is achieved, and then switch patients to controlled-release opioids. Most patients with chronic non-malignant pain can be managed with<300 mg/d of morphine (or equivalent).
CONCLUSION: Opioids are safe and effective for managing chronic pain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17279219      PMCID: PMC1783736     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  74 in total

1.  Deaths in the first two weeks of maintenance treatment in NSW in 1994: identifying cases of iatrogenic methadone toxicity.

Authors:  J R Caplehorn
Journal:  Drug Alcohol Rev       Date:  1998-03

2.  Chronic pain prevalence and analgesic prescribing in a general medical population.

Authors:  J David Clark
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

Review 3.  Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

Authors:  S L Collins; R A Moore; P Wiffen
Journal:  J Pain Symptom Manage       Date:  2000-12       Impact factor: 3.612

4.  The importance of somatic symptoms in depression in primary care.

Authors:  André Tylee; Paul Gandhi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

5.  Tramadol exposures reported to statewide poison control system.

Authors:  Kathy A Marquardt; Judith A Alsop; Timothy E Albertson
Journal:  Ann Pharmacother       Date:  2005-05-03       Impact factor: 3.154

6.  The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain.

Authors:  S Chary; B R Goughnour; D E Moulin; W R Thorpe; Z Harsanyi; A C Darke
Journal:  J Pain Symptom Manage       Date:  1994-08       Impact factor: 3.612

7.  Coronary artery disease and opioid use.

Authors:  Michael Marmor; Arthur Penn; Kyle Widmer; Richard I Levin; Robert Maslansky
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

8.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

9.  Depressed mood impedes pain treatment response in patients with fibromyalgia.

Authors:  Arnstein Finset; Sigrid Hørven Wigers; K Gunnar Götestam
Journal:  J Rheumatol       Date:  2004-05       Impact factor: 4.666

10.  Principles of cancer pain management. Use of long-acting oral morphine.

Authors:  I Brooks; R De Jager; M Blumenreich; E George; J J Savarese
Journal:  J Fam Pract       Date:  1989-03       Impact factor: 0.493

View more
  11 in total

1.  Does chronic opioid use really reduce pain?

Authors:  David Howe
Journal:  Can Fam Physician       Date:  2006-12       Impact factor: 3.275

2.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.

Authors:  Meldon Kahan; Angela Mailis-Gagnon; Lynn Wilson; Anita Srivastava
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

Review 3.  Opioids for the treatment of chronic non-cancer pain in older people.

Authors:  Walter Gianni; Moira Ceci; Silvia Bustacchini; Andrea Corsonello; Angela Marie Abbatecola; Anna Maria Brancati; Antonio Assisi; Angelo Scuteri; Luca Cipriani; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

4.  Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study.

Authors:  Antonio Gatti; Alessandro Fabrizio Sabato; Annalisa Carucci; Laura Bertini; Massimo Mammucari; Roberto Occhioni
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 5.  Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.

Authors:  Taha Ahmad; Monica A Valentovic; Gary O Rankin
Journal:  Biochem Pharmacol       Date:  2018-02-16       Impact factor: 5.858

6.  Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients.

Authors:  Fabio Guerriero; Carmelo Sgarlata; Claudio Marcassa; Giovanni Ricevuti; Marco Rollone
Journal:  Clin Interv Aging       Date:  2014-12-16       Impact factor: 4.458

7.  Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada.

Authors:  Tejal Patel; Feng Chang; Heba Tallah Mohammed; Lalitha Raman-Wilms; Jane Jurcic; Ayesha Khan; Beth Sproule
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

Review 8.  Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain.

Authors:  J Devulder; A Jacobs; U Richarz; H Wiggett
Journal:  Br J Anaesth       Date:  2009-09-06       Impact factor: 9.166

9.  Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.

Authors:  Fabio Guerriero; Anna Roberto; Maria Teresa Greco; Carmelo Sgarlata; Marco Rollone; Oscar Corli
Journal:  Drug Des Devel Ther       Date:  2016-04-19       Impact factor: 4.162

10.  Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation.

Authors:  Marzia Lazzari; Claudio Marcassa; Silvia Natoli; Roberta Carpenedo; Clarissa Caldarulo; Maria B Silvi; Mario Dauri
Journal:  Clin Interv Aging       Date:  2016-05-13       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.